Publication date: Feb 13, 2020
Reduction in Dietary Methionine May Achieve Better Outcomes for Patients with Multiple Sclerosis Significantly reducing dietary levels of the amino acid methionine could slow the onset and progression of inflammatory and autoimmune disorders, such as multiple sclerosis (MS) in patients with a high-risk.
The study’s findings suggest that patients predisposed to inflammatory and autoimmune disorders such as MS may benefit from reducing methionine intake. -These findings provide further basis for dietary interventions as future treatments for these disorders,” said Russell Jones, PhD, senior study author and program leader of Van Andel Institute’s Metabolic and Nutritional Programming group. During an immune response, T cells flood the affected area to help the body fend off pathogens.
This inflammation is a normal part of an immune response but could cause damage if it lingers, such as the nerve damage that occurs in MS. According to the study authors, restricting methionine in the diet removes the fuel for this overactive inflammatory response without compromising the rest of the immune system. Autoimmune disorders occur when the immune system mistakenly attacks and destroys healthy tissue.
- Dietary Intercession Retard Outset Of Inflammatory And Autoimmune Illnesses
- Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming.
- MS 101: Back To Basics – 1st Presentation at 2019 MS Symposium